The most down-regulated gene in prostate cancer is serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) member 3(SERPINA3), whose protein product Alpha 1 antichymotrypsin (ACT) is associated with increased risk of prostate cancer [25]. This evidence concerns the gene SERPINA3 and Familial prostate cancer.